Under experimental conditions, antibody-mediated blocking of HLA class I molecules on CD8 + T-lymphocytes from the blood of RA ACPA+ patients resulted in non-activation of these cells when exposed to citrullinated peptides [31]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.